Senology.org - Newsletter

International Senologic and Oncologic  Scientific Community (ISOSC) 

"Connecting specialists worldwide"

April 10, 2013

Editor-in-Chief: Gian Paolo Andreoletti, MD

 

Join us on  LinkedInTwitter, Facebook, YouTube, ResearchGateSlideShare, Flickr, and share comments. 

Read Senology Newspaper daily

 

Senology collaborates with 

  

Literature Selection

Editorial

Questions and Answers 

Fragments of History

Calendar of Events

 

HEALTHCARE INDUSTRY NEWS

  Bracco receives MHRA approval for expanded labeling of MultiHance® (gadobenate dimeglumine) in magnetic resonance imaging of the breast 

Press release - Milan (Italy), March 11, 2013 - " Bracco receives MHRA approval for expanded labeling of gadobenate dimeglumine in Magnetic Resonance Imaging of the breast. - MultiHance®, the highest relaxivity contrast agent for MRI of the central nervous system, is now approved for breast MRI " (read more)

 

 

Literature Selection

Discussion

  •   "Intermittent versus continuous androgen deprivation in prostate cancer " -  Share your opinion on  LinkedIn

Questions and Answers 

 

 

Subscribe          Unsubscribe          Contact          Back Issues

     

www.senology.org